Surgery in patients with congenital factor VII deficiency - a single center study
Journal Title: Polish Journal of Surgery - Year 2018, Vol 90, Issue 5
Abstract
Introduction: Congenital factor VII deficiency is a rare hemorrhagic disorder inherited in an autosomal recessive pattern. Surgical treatment with insufficient diathesis correction is burdened with high risk of bleeding complications. The aim of the study was evaluation of the surgical outcome in patients with congenital factor VII deficiency and assessment of the efficacy and safety of recombinant activated factor VII (rFVIIa) used for perioperative hemostatic coverage in our two schemas of substitutive therapy. Material and methods: In the years 2002-2017 a total of 22 patients with congenital factor VII deficiency were subjected to surgery. Substitution therapy relied on rFVIIa used in two schemas. One involved 15 patients with factor VII activity of<10% of normal value who were injected rFVIIa at a dose of 30 μg/kg b.w. every12 hours on surgery day, 15 μg/kg b.w. every 12 hours on the first postoperative day and 15 μg/kg b.w. every 24 hours on the following days. The second schema involved 7 patients with factor VII activity of 10-25% of normal value who were given rFVIIa at a dose of 15 μg/kg b.w. every 12 hours on surgery day and the first postoperative day; then the same dose was administered every 24 hours on consecutive days. The treatment continued for 4-10 days. Results: In the 22 patients a total of 26 surgeries were performed; 17 surgeries in 15 patients with factor VII<10% of normal and 9 in 7 patients with factor VII deficiency of 10-25% of normal. The surgeries included: 9 cholecystectomies (8 laparoscopic,1 open), 7 thyroidectomy procedures, 2 exploratory laparotomies, 1 left hemicolectomy, 1 total proctocolectomy, 3 inguinal hernia repairs and 3 excisions of varicose veins. One patient with factor VII activity of 9% required an additional dose of rFVIIa in the intraoperative period due to diathesis bleeding. Intraoperative hemostasis was normal for all other patients; no postoperative hemorrhagic complications were reported. In patients with FVII activity<10% average daily dose of rFVIIa was 31.3(range 20-56) μg/kg b.w., total daily dose 186(136-303) µg/kg b.w., total dose of rFVIIa-15.2(12-112) mg. In patients with FVII activity 10-25% the doses were 21.2(15-31), 117(46-271) µg/kg b.w. and 9.1(6-17) mg respectively. Conclusions: Surgery in patients with congenital factor VII deficiency can be safely and efficiently performed with rFVIIa as substitutive treatment securing perioperative hemostasis. <br/><br/>
Authors and Affiliations
Andrzej Szczepanik, Adam Wiszniewski, Anna Oses-Szczepanik, Wojciech Dąbrowski, Konrad Pielaciński
Keywords
Related Articles
- EP ID EP346421
- DOI 10.5604/01.3001.0012.0668
- Views 92
- Downloads 0
Influence of Internal Carotid Endarterectomy on Patients' Life Quality
Posterior component separation – pierwsze polskie doniesienie o zastosowaniu nowej techniki operacyjnej w leczeniu dużych przepuklin brzusznych
-
Evaluation of inflammatory markers as predictors of hospital stay and unplanned readmission after colorectal surgery
Hospital length of stay (LOS) and readmissions continue to be expensive and unexpected events following colorectal surgery (CRS) whether patients follow enhanced recovery pathways or traditional care. Predictors of these...
Aortoesophageal Fistula – Rare Complication after Esophagogastrectomy, due to Cancer
The paper contains a description of the case – 63 year old patient with surgery due locally advanced cancer of the gastric cardia. In 28 postoperative day symptoms of GI bleeding occurred. Despite the endoscopic attempts...
Distribution of lip and/or palate clefts types among children form Lodz during years 1981-2015
Introduction. Cleft lip and/or palate are the most common face malformations. Clinical picture of these anomalies is very variable. Cleft can include only lip and/or alveolus, palate or all of these structures can be cle...